Key drivers for North America include strong ecosystem maturity, high adoption rates of advanced materials, and significant investments in research and development. In Europe, key drivers include stringent policies and regulations promoting the use of antibacterial materials, a mature infrastructure, and a high level of awareness about the importance of infection control. Asia Pacific is driven by a large and growing population, increasing demand for healthcare services, and significant investments in the healthcare sector. Latin America is driven by growing demand for advanced medical products, increasing awareness about the benefits of antibacterial materials, and improving infrastructure. Middle East & Africa is driven by growing demand for healthcare services, increasing investments in the healthcare sector, and a rising awareness about the importance of infection control.